Discordance in the epithelial cell-dendritic cell MHC class II immunoproteome: implications for Chlamydia vaccine development.
Chlamydia trachomatis and C. muridarum are intracellular bacterial pathogens of mucosal epithelial cells. CD4 T cells and major histocompatibility complex (MHC) class II molecules are essential for protective immunity against them. Antigens presented by dendritic cells (DCs) expand naïve pathogen-specific T cells (inductive phase), while antigens presented by epithelial cells identify infected epithelial cells as targets during the effector phase. We previously showed that DCs infected by C. trachomatis or C. muridarum present epitopes from a limited spectrum of chlamydial proteins recognized by Chlamydia-specific CD4 T cells from immune mice. We hypothesized that Chlamydia-infected DC and epithelial cells present overlapping sets of Chlamydia-MHC class II epitopes to link inductive and effector phases to generate protective immunity. We tested that hypothesis by infecting an oviductal epithelial cell line with C. muridarum, followed by immunoaffinity isolation and sequencing of MHC class I- and II-bound peptides. We identified 26 class I-bound and 4 class II-bound Chlamydia-derived peptides from infected epithelial cells. Surprisingly none of the epithelial cell class I- and class II-bound chlamydial peptides overlapped with peptides presented by DCs. We suggest the discordance between the dendritic and epithelial cell immunoproteomes has implications for delayed clearance of Chlamydia and design of a Chlamydia vaccine.